Skip to main content



 Third Annual Conference on Brain Metastases


Join the Society for Neuro-Oncology, and the AANS/CNS Section on Tumors, for the 3rd Annual Conference on Brain Metastases on August 19-21, 2021.

Registration for the conference will open soon.

Who Should Attend
Neuro-oncologist, medical oncologist, neurosurgeons, radiation oncologist, radiologist, physicians/scientists, clinical and laboratory trainees, allied health professionals, pharmacists, and other medical professionals with an interest in metastatic disease.

The abstract submission deadline has passed. 
Abstract Submission Categories

The conference organizers welcome the submission of original research on the following topics:
  • Basic Science
  • Leptomeningeal Disease
  • Clinical Trials
  • Medical Therapy (Chemotherapy and Immunotherapy)
  • Multimodality
  • Radiation
  • Surgery
  • Other

Accepted Abstracts will be published in Neuro-Oncology Advances

What to Expect
  • Lectures, Q&A sessions, posters, and poster discussions
  • Live activities to earn AMA PRA Category 1 Credits™  
  • Accepted abstracts to be published in SNO's journal, Neuro-Oncology-Advances
Learning Objectives
  • Indicate all available treatment options for management of LMD patients. 
  • Identify methods to assess QOL and any factors that may contribute to a decline in QOL.  
  • Summarize unique issues in the design of clinical trials for brain metastases. 
  • Recognize LITT as a treatment option for brain metastases. 
  • Identify immunotherapy options for treatment of brain metastases. Lectures, Q&A sessions, posters, and poster discussion.
Scientific Program Co-Chairs
Adrienne Boire 
Memorial Sloan Kettering Cancer Center

Paul Kongkham
University of Toronto

Rohan Ramakrishna
Weill Cornell Medicine

David Shultz
University of Toronto

Quick Links